» Articles » PMID: 37193737

DNA Methylation Variations and Epigenetic Aging in Telomere Biology Disorders

Overview
Journal Sci Rep
Specialty Science
Date 2023 May 16
PMID 37193737
Authors
Affiliations
Soon will be listed here.
Abstract

Telomere Biology Disorders (TBDs) are characterized by mutations in telomere-related genes leading to short telomeres and premature aging but with no strict correlation between telomere length and disease severity. Epigenetic alterations are also markers of aging and we aimed to evaluate whether DNA methylation (DNAm) could be part of the pathogenesis of TBDs. In blood from 35 TBD cases, genome-wide DNAm were analyzed and the cases were grouped based on relative telomere length (RTL): short (S), with RTL close to normal controls, and extremely short (ES). TBD cases had increased epigenetic age and DNAm alterations were most prominent in the ES-RTL group. Thus, the differentially methylated (DM) CpG sites could be markers of short telomeres but could also be one of the mechanisms contributing to disease phenotype since DNAm alterations were observed in symptomatic, but not asymptomatic, cases with S-RTL. Furthermore, two or more DM-CpGs were identified in four genes previously linked to TBD or telomere length (PRDM8, SMC4, VARS, and WNT6) and in three genes that were novel in telomere biology (MAS1L, NAV2, and TM4FS1). The DM-CpGs in these genes could be markers of aging in hematological cells, but they could also be of relevance for the progression of TBD.

Citing Articles

Semimethylation is a feature of diffuse large B-cell lymphoma, and subgroups with poor prognosis are characterized by global hypomethylation and short telomere length.

Carlund O, Thorn E, Osterman P, Fors M, Dernstedt A, Forsell M Clin Epigenetics. 2024; 16(1):68.

PMID: 38773655 PMC: 11110316. DOI: 10.1186/s13148-024-01680-4.


Racial disparity in uterine leiomyoma: new insights of genetic and environmental burden in myometrial cells.

Khan N, McNally R, Kim J, Wei J Mol Hum Reprod. 2024; 30(3).

PMID: 38290796 PMC: 10904341. DOI: 10.1093/molehr/gaae004.

References
1.
Levine M, Lu A, Quach A, Chen B, Assimes T, Bandinelli S . An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018; 10(4):573-591. PMC: 5940111. DOI: 10.18632/aging.101414. View

2.
Gadalla S, Katki H, Shebl F, Giri N, Alter B, Savage S . The relationship between DNA methylation and telomere length in dyskeratosis congenita. Aging Cell. 2011; 11(1):24-8. PMC: 3257380. DOI: 10.1111/j.1474-9726.2011.00755.x. View

3.
Ehrlich M . DNA hypermethylation in disease: mechanisms and clinical relevance. Epigenetics. 2019; 14(12):1141-1163. PMC: 6791695. DOI: 10.1080/15592294.2019.1638701. View

4.
Weyburne E, Bosco G . Cancer-associated mutations in the condensin II subunit CAPH2 cause genomic instability through telomere dysfunction and anaphase chromosome bridges. J Cell Physiol. 2020; 236(5):3579-3598. PMC: 7983937. DOI: 10.1002/jcp.30113. View

5.
Cypris O, Eipel M, Franzen J, Rosseler C, Tharmapalan V, Kuo C . PRDM8 reveals aberrant DNA methylation in aging syndromes and is relevant for hematopoietic and neuronal differentiation. Clin Epigenetics. 2020; 12(1):125. PMC: 7439574. DOI: 10.1186/s13148-020-00914-5. View